Revenue
attach_money20M USD
YoY +36.7%
SNOASonoma Pharmaceuticals, Inc.$ --
Sonoma Pharmaceuticals, Inc.
SNOA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2026 Full YearUpdated: 03/31/2026
Operating Income
bar_chart-2M USD
YoY +33.7%
Net Income
verified-3M USD
YoY +8.2%
EPS
pie_chart-1.89USD
YoY +32.3%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress158.9%On Track
Revenue Progress19.5M
Revenue Forecast20.7M
Net Income Progress-3.2M
Net Income Forecast-2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.